AKTS Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development RYAM Q1 2026 Earnings Significant EPS Miss Amid Stock Resilience ALDX Q1 2026 Earnings Narrower Loss Beats Estimates Stock Surges GEOS Q1 2026 Earnings Reported Loss of 086 Per Share as Market Conditions Remain Pressured EHTH Q1 2026 Earnings EPS Misses Estimates by 3466 Shares Fall 37 Atea Pharmaceuticals Q1 2026 Earnings Narrower Loss Beats Expectations Stock Edges Higher